Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Fate Therapeutics (FATE)

Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 455,328
  • Shares Outstanding, K 113,832
  • Annual Sales, $ 63,530 K
  • Annual Income, $ -160,930 K
  • 60-Month Beta 1.84
  • Price/Sales 7.10
  • Price/Cash Flow N/A
  • Price/Book 1.15
Trade FATE with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( -59.85%)
  • Historical Volatility 73.64%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 506.59% on 10/20/23
  • IV Low 0.00% on 09/18/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 64
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 1,956
  • Open Int (30-Day) 1,684

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.42
  • Number of Estimates 9
  • High Estimate -0.39
  • Low Estimate -0.46
  • Prior Year -0.46
  • Growth Rate Est. (year over year) +8.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.33 +16.69%
on 09/03/24
4.17 -6.95%
on 09/16/24
+0.48 (+14.12%)
since 08/16/24
3-Month
3.03 +28.26%
on 07/09/24
5.92 -34.46%
on 07/26/24
+0.47 (+13.78%)
since 06/18/24
52-Week
1.63 +138.04%
on 10/30/23
8.83 -56.06%
on 03/07/24
+1.33 (+52.16%)
since 09/18/23

Most Recent Stories

More News
Fate Therapeutics: Q2 Earnings Snapshot

Fate Therapeutics: Q2 Earnings Snapshot

FATE : 3.88 (-3.00%)
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?

The Baker brothers are billionaires with a successful track record in the biopharmaceutical industry.

MRK : 118.64 (+0.30%)
LLY : 904.97 (-0.13%)
PFE : 29.75 (-0.27%)
OPHLY : 4.4600 (+0.22%)
ABCL : 2.75 (+0.73%)
FATE : 3.88 (-3.00%)
Fate Therapeutics: Q1 Earnings Snapshot

Fate Therapeutics: Q1 Earnings Snapshot

FATE : 3.88 (-3.00%)
5 Russell 2000 Stocks Outperforming the 'Magnificent Seven' in 2024

The "Magnificent Seven" have lost some momentum in 2024, just as small-caps are starting to come on strong. Here's a closer look at five Russell 2000 stocks that are crushing the performance of their mega-cap...

GOOGL : 159.81 (+0.31%)
AMZN : 186.43 (-0.24%)
AAPL : 220.69 (+1.80%)
META : 537.95 (+0.30%)
MSFT : 430.81 (-1.00%)
NVDA : 113.37 (-1.92%)
TSLA : 227.20 (-0.29%)
MAGS : 45.05 (-0.18%)
$IUXX : 19,344.49 (-0.45%)
VKTX : 64.45 (+2.40%)
SOUN : 4.85 (+1.04%)
APGE : 53.34 (+5.33%)
Fate Therapeutics: Q4 Earnings Snapshot

Fate Therapeutics: Q4 Earnings Snapshot

FATE : 3.88 (-3.00%)
Fate Therapeutics: Q3 Earnings Snapshot

Fate Therapeutics: Q3 Earnings Snapshot

FATE : 3.88 (-3.00%)
Fate Therapeutics: Q2 Earnings Snapshot

Fate Therapeutics: Q2 Earnings Snapshot

FATE : 3.88 (-3.00%)
Why Shares of Fate Therapeutics Soared This Week

The company's shares bounced back after a stock sale last week.

JNJ : 166.15 (-0.55%)
OPHLY : 4.4600 (+0.22%)
FATE : 3.88 (-3.00%)
MFG : 3.93 (unch)
Fate Therapeutics: Q1 Earnings Snapshot

Fate Therapeutics: Q1 Earnings Snapshot

FATE : 3.88 (-3.00%)
FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fate Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important March 22 Deadline in Securities Class Action – FATE

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fate Therapeutics, Inc. (NASDAQ: FATE) between April 2, 2020 and January 5, 2023, both dates inclusive (the...

FATE : 3.88 (-3.00%)

Business Summary

Fate Therapeutics is a clinical-stage biopharmaceutical company, which is focused on the development of programmed cellular immunotherapies for cancer and immune disorders.' The company uses various therapeutic approaches for cell programming to develop cell therapies. The company programs cells of the...

See More

Key Turning Points

3rd Resistance Point 4.33
2nd Resistance Point 4.23
1st Resistance Point 4.12
Last Price 3.88
1st Support Level 3.91
2nd Support Level 3.81
3rd Support Level 3.70

See More

52-Week High 8.83
Fibonacci 61.8% 6.08
Fibonacci 50% 5.23
Fibonacci 38.2% 4.38
Last Price 3.88
52-Week Low 1.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar